ACRV vs AEP · $65.1M cap vs P/E 19, rev $21.88B
Acrivon Therapeutics, Inc. Common Stock (ACRV) versus American Electric Power Co Inc (AEP) — a side-by-side from cached financials, not a winner call.
Acrivon Therapeutics, Inc. Common Stock (ACRV) is a biotechnology company listed on NASDAQ.
American Electric Power Co Inc (AEP) is a utilities - regulated electric company listed on NASDAQ.
ACRV does not have a complete income-statement cache yet.
Latest reported AEP revenue for 2025-12-31 was $21.88B. Net income was $3.70B. Revenue was up 9.5% from 2024-12-31 to 2025-12-31. AEP currently screens at market cap $69.79B and trailing P/E 19.0.
ACRV currently screens at market cap $65.1M. AEP currently screens at market cap $69.79B and trailing P/E 19.0.
Not investment advice. Open the ACRV and AEP stock pages for the full models.
Not investment advice.